News + Filings Transactions Holdings
|
Polaris Venture Management Co. V, L.L.C.
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Common Stock | 994k | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Common Stock | 19.4k | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Common Stock | 9.9k | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Common Stock | 6.8k | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Sale | Common Stock | 9.3k | $16.00 | $149.3k | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Sale | Common Stock | 182 | $16.00 | $2.9k | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Sale | Common Stock | 94 | $16.00 | $1.5k | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Sale | Common Stock | 64 | $16.00 | $1k | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Purchase | Common Stock | 60.3k | $16.00 | $964.9k | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Purchase | Common Stock | 1.2k | $16.00 | $18.8k | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Purchase | Common Stock | 603 | $16.00 | $9.6k | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Purchase | Common Stock | 413 | $16.00 | $6.6k | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Series A-1/C Convertible Preferred Stock | 6.3M | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Series A-1/C Convertible Preferred Stock | 122.2k | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Series A-1/C Convertible Preferred Stock | 62.7k | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Series A-1/C Convertible Preferred Stock | 42.9k | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Series A-2 Convertible Preferred Stock | 3.3M | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Series A-2 Convertible Preferred Stock | 64.2k | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Series A-2 Convertible Preferred Stock | 33k | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Series A-2 Convertible Preferred Stock | 22.6k | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Series A-3 Convertible Preferred Stock | 8.6M | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Series A-3 Convertible Preferred Stock | 167.8k | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Series A-3 Convertible Preferred Stock | 86.1k | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Series A-3 Convertible Preferred Stock | 59k | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Series A-4 Convertible Preferred Stock | 7.7M | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Series A-4 Convertible Preferred Stock | 149.9k | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Series A-4 Convertible Preferred Stock | 76.9k | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Series A-4 Convertible Preferred Stock | 52.7k | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Series B Convertible Preferred Stock | 6.4M | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Series B Convertible Preferred Stock | 125.1k | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Series B Convertible Preferred Stock | 64.2k | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Series B Convertible Preferred Stock | 44k | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Series C Convertible Preferred Stock | 2M | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Series C Convertible Preferred Stock | 38.8k | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Series C Convertible Preferred Stock | 19.9k | $0.00 | $0 | See footnote | 05/05/2020 |
|
|